Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Total Deferred Tax Assets Net of Valuation Allowance by Year
Total Deferred Tax Assets Net of Valuation Allowance ($M) ($M)
Amgen Total Deferred Tax Assets Net of Valuation Allowance: $5,624M in FY2025, up 13.0% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Income Taxes Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Deferred Tax Assets Net of Valuation Allowance ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,624 | +13.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 4,976 | +9.3% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 4,554 | +61.5% | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 2,819 | +69.0% | Form 10-K (filed 2024-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 1,668 | +26.3% | Form 10-K (filed 2023-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 1,321 | +4.0% | Form 10-K (filed 2022-02-16) ↗ |
| FY2019 | Dec 31, 2019 | 1,270 | +7.4% | Form 10-K (filed 2021-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 1,183 | +9.0% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 1,085 | -22.9% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 1,408 | -16.3% | Form 10-K (filed 2018-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 1,682 | – | Form 10-K (filed 2017-02-14) ↗ |
Cite this data
StockData. (2026). Amgen Total Deferred Tax Assets Net of Valuation Allowance ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/dta-net
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.